Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
8
×
san francisco blog main
8
×
startups
8
×
national top stories
san francisco top stories
biotech
boston blog main
boston top stories
new york top stories
deals
san diego blog main
boulder/denver blog main
cancer
san diego top stories
vc
wisconsin blog main
wisconsin top stories
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
national
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
aducanumab
alzheimer's disease
asklepios biopharmaceutical
biogen
cancer immunotherapy
cell therapy
What
new
8
×
medicines
bio
developing
drugs
roundup
startup
biotech
venture
activity
adds
aim
aiming
aims
ambys
analyzes
approach
approval
approvals
bails
based
big
bigger
biogen
biogen’s
biopharmaceutical
boost
brand
bridgebio
called
cancer
capital
car
ceo
change
clamped
community
companies
company
control
Language
unset
Current search:
new
×
startups
×
" san francisco blog main "
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO